Generate:Biomedicines Announces Publication of its Chroma Model in Nature
15 Nov 2023 //
BUSINESSWIRE
Generate:Biomedicines Appoints Dr. Alexandra Snyder as Executive VP
12 Jun 2023 //
BUSINESSWIRE
Generate Biomedicines to Present at Annual J.P. Morgan Healthcare Conference
05 Jan 2023 //
BUSINESSWIRE
Generate Biomedicines Expands Board of Directors With Jane Mendillo
07 Dec 2022 //
BUSINESSWIRE
Generate Biomedicines Demonstrates a Method of Reducing Immunogenicity
07 Dec 2022 //
BUSINESSWIRE
Generate Biomedicines Expands Leadership Team with Chief Digital Officer
06 Dec 2022 //
BUSINESSWIRE
Generate Biomedicines Uses AI to Create Proteins That Have Never Existed
01 Dec 2022 //
BUSINESSWIRE
Generate Biomedicines Grows Leadership Team with Senior VP
22 Nov 2022 //
BUSINESSWIRE
Generate Biomedicines Expands Leadership Team with Addition of CMO
26 Jul 2022 //
BUSINESSWIRE
Generate Biomedicines Bolsters Leadership Team; Appoints Jason Silvers as CFO
25 Jul 2022 //
BUSINESSWIRE
Amgen chooses Generate in $1.9B biobucks deal to churn 10 multispecific drugs
07 Jan 2022 //
PRESS RELEASE